SMG-1 inhibition by miR-192/-215 causes epithelial-mesenchymal transition in gastric carcinogenesis via activation of Wnt signaling
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SMG-1 inhibition by miR-192/-215 causes epithelial-mesenchymal transition in gastric carcinogenesis via activation of Wnt signaling
Authors
Keywords
-
Journal
Cancer Medicine
Volume 7, Issue 1, Pages 146-156
Publisher
Wiley
Online
2017-12-14
DOI
10.1002/cam4.1237
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FERMT1 mediates epithelial–mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity
- (2016) C-C Liu et al. ONCOGENE
- World Health Organization. Comprehensive Implementation Plan on Maternal, Infant, and Young Child Nutrition. Geneva, Switzerland, 2014
- (2015) Shelley McGuire Advances in Nutrition
- MiR-215/192 participates in gastric cancer progression
- (2014) Y. J. Xu et al. Clinical & Translational Oncology
- Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype
- (2014) Ana Ferro et al. EUROPEAN JOURNAL OF CANCER
- SMG1 Acts as a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia
- (2014) Yahui Du et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PRRX1 promotes epithelial–mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer
- (2014) Jinbao Guo et al. MEDICAL ONCOLOGY
- Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma
- (2014) LI-LI HAN et al. ONCOLOGY REPORTS
- Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22
- (2013) Hailin Tang et al. CANCER LETTERS
- miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma
- (2013) H.W.Z. Khella et al. CARCINOGENESIS
- SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways
- (2013) Evgenia Gubanova et al. CELL CYCLE
- Epithelial-mesenchymal plasticity in carcinoma metastasis
- (2013) J. H. Tsai et al. GENES & DEVELOPMENT
- Management of gastric cancer in Asia: resource-stratified guidelines
- (2013) Lin Shen et al. LANCET ONCOLOGY
- EphA2 promotes epithelial–mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells
- (2013) J Huang et al. ONCOGENE
- Downregulation of SMG-1 in HPV-Positive Head and Neck Squamous Cell Carcinoma Due to Promoter Hypermethylation Correlates with Improved Survival
- (2012) Evgenia Gubanova et al. CLINICAL CANCER RESEARCH
- microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer
- (2011) YEUNPO CHIANG et al. Experimental and Therapeutic Medicine
- E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-
- (2010) B. Wang et al. DIABETES
- Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression
- (2010) Douglas S. Micalizzi et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro
- (2010) Z Jin et al. ONCOGENE
- Epithelial-Mesenchymal Transition and Cell Cooperativity in Metastasis
- (2009) T. Tsuji et al. CANCER RESEARCH
- A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans
- (2009) Hui Li et al. JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started